Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV

NCT04849182 NA COMPLETED

Randomized, 3-arm controlled clinical study, to evaluate the effectiveness of supplementation with Vertistop® D (food supplement containing alpha-lipoic acid at modified release, Carnosine and Zinc, Vitamin D and Vitamins B) and Vertistop® L (food supplement containing fast releasing alpha-lipoic acid, Carnosine, Zinc and Curcumin) in preventing recurrence of high-recurrence BPPV (Benign Paroxysmal Positional Vertigo)

Details

Lead sponsor	Azienda Sanitaria Locale di Matera
Phase	NA
Status	COMPLETED
Enrolment	128
Start date	Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Benign Paroxysmal Positional Vertigo (BPPV)

Interventions

• Vertistop D
• Vertistop L

Countries

Italy